IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $312,012 | -86.7% | 32,400 | -85.4% | 0.00% | -90.0% |
| Q2 2023 | $2,354,397 | +669.3% | 221,278 | +795.9% | 0.02% | +566.7% |
| Q4 2022 | $306,033 | -79.8% | 24,700 | -83.1% | 0.00% | -76.9% |
| Q3 2022 | $1,517,000 | +223.5% | 146,563 | +264.6% | 0.01% | +225.0% |
| Q4 2021 | $469,000 | -3.1% | 40,200 | +8.6% | 0.00% | -20.0% |
| Q3 2021 | $484,000 | -20.3% | 37,000 | -21.5% | 0.01% | -16.7% |
| Q2 2021 | $607,000 | +177.2% | 47,118 | +117.4% | 0.01% | -57.1% |
| Q1 2020 | $219,000 | +12.3% | 21,677 | +48.2% | 0.01% | +180.0% |
| Q4 2019 | $195,000 | +107.4% | 14,623 | +34.2% | 0.01% | +66.7% |
| Q3 2019 | $94,000 | -92.0% | 10,900 | -85.7% | 0.00% | -96.6% |
| Q1 2018 | $1,176,000 | -17.4% | 76,195 | +1.0% | 0.09% | -40.1% |
| Q2 2017 | $1,424,000 | -69.7% | 75,411 | -72.6% | 0.15% | -68.9% |
| Q1 2017 | $4,704,000 | +70.1% | 275,712 | +52.4% | 0.47% | +31.8% |
| Q4 2016 | $2,766,000 | – | 180,881 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |